Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Nurses caring for a COVID-19 patient in the COVID unit at Banner University Medical Center in Phoenix.

An updated look at what cardiologists know about heart damage among COVID-19 patients

An international analysis published in Circulation and a new scientific statement from the American Heart Association both explore the latest data on heart complications associated with COVID-19. 

An implantable cardioverter defibrillator (ICD) and its associated leads viewed on a X-ray. Old leads are often abandon in veins and new ones added, but a new study of 1 million patients at ACC22 showed there is higher mortality if a device becomes infected and the leads are left behind. Image from RSNA.

VIDEO: Lowering mortality rates from infected EP implantable cardiac devices

Sean Pokorney, MD, director of the arrhythmia core lab, Duke Clinical Research Institute, assistant professor of Medicine, Duke University, discusses a late-breaking ACC 2022 study that shows mortality is higher in patients with implantable electrophysiology (EP) device infections where the leads are not explanted.

A late-breaking study at ACC.22 showed differences in COVID-positive heart attack patients between 2020 and 2021. #ACC22 #ACC2022

VIDEO: Vaccines boosted survival among STEMI heart attack patients with COVID-19

Santiago Garcia, MD, lead author of the study and director of the structural heart program at The Christ Hospital in Cincinnati, Ohio, presented new data from the North American COVID-19 STEMI (NACMI) registry at ACC.22. Severity of heart attacks were reduced in vaccinated patients, with zero deaths in vaccinated patients in 2021.

Los Angeles, California

Australian tech company opens new US office, eyes FDA approval for AI CAD solution

The company's flagship offering uses AI to evaluate 3D images of a patient's heart for signs of atherosclerotic plaque.

District of Columbia DC congress capitol hill

CMS delays start of Radiation Oncology Alternative Payment Model yet again

The mandatory bundled payment initiative was slated to kick off Jan. 1, 2023, following numerous delays, but will now launch on a to-be-determined date.

AI model able to ID early signs of type 2 diabetes on imaging results

The authors hope their findings could lead to earlier diagnoses and improvements in patient care. 

Thumbnail

AI predicts COVID prognosis at near-expert level using CT scoring system

A deep convolutional neural network was able to predict hospital stay, ICU admission and intubation when scoring chest CT images of hospitalized COVID patients.

Imaging suggests blood clots are more common in COVID than pneumonia

In a recent study, venous thromboembolisms were detected in those with COVID via multiple imaging modalities at a rate of 16.3% compared to 9.2% in individuals with CAP.

Around the web

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel.